A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Lot Consistency Trial)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03365921
Recruitment Status : Withdrawn (The adjuvant of vaccine might change, this study will be conducted with new adjuvant.)
First Posted : December 7, 2017
Last Update Posted : January 11, 2018
Jiangsu Province Centers for Disease Control and Prevention
Information provided by (Responsible Party):
Xiamen Innovax Biotech Co., Ltd

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : July 2018
  Estimated Study Completion Date : July 2018